Pharma News

GENEVA (Reuters) - The World Health Organization will resume its trial of hydroxychloroquine for potential use against the coronavirus, its chief said on Wednesday, after those running the stu...

A Trump administration program to get 200,000 uninsured patients access to the HIV prevention drug Truvada only has 891 participants, HHS Assistant Secretary for Health Brett Giroir said Monday at a v...

ZURICH (Reuters) - Lonza aims to speed completion of two commercial production lines for Moderna Inc’s trial COVID-19 vaccine so manufacturing could start four to six weeks earlier than plan...

(Reuters) - Gilead Sciences Inc (GILD.

New York City's first confirmed COVID-19 cases stemmed primarily from European and United States sources, according to the first molecular epidemiology study of SARS-CoV-2 from researchers at the ...

(Reuters) - U.

AstraZeneca has secured approval from the US Food and Drug Administration (FDA) for its Brilinta (ticagrelor) to minimise the risk of a first heart attack or stroke in high-risk patien...

The U.

The FDA previously found low levels of NDMA in tested metformin that it said did not necessitate recalls.

NEW DELHI.

TAIPEI (Reuters) - Taiwan’s government said on Saturday it had approved Gilead Sciences’ potential COVID-19 treatment, remdesivir, to treat the illness caused by the novel coronavirus.

HONG KONG (Reuters) - A Chinese-made coronavirus vaccine could be ready for market as early as the end of this year, China’s State-owned Assets Supervision and Administration Commission (...